Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

Interventional Management of Stroke (IMS) III Trial
Interventional Management of Stroke Trial: A Phase III Clinical Trial Examining Whether a Combined Intravenous (IV) and Intra-Arterial (IA) Approach to Recanalization is Superior to Standard IV Rt-PA (Activase®) Alone When Initiated Within Three Hours of Acute Ischemic Stroke Onset
Status: Archived
Lehigh Valley Hospital Center, 1200 South Cedar Crest Blvd.
mi
from
Allentown, PA
Interventional Management of Stroke (IMS) III Trial
Interventional Management of Stroke Trial: A Phase III Clinical Trial Examining Whether a Combined Intravenous (IV) and Intra-Arterial (IA) Approach to Recanalization is Superior to Standard IV Rt-PA (Activase®) Alone When Initiated Within Three Hours of Acute Ischemic Stroke Onset
Status: Archived
Updated: 1/1/1970
Lehigh Valley Hospital Center, 1200 South Cedar Crest Blvd.
mi
from
Allentown, PA
Interventional Management of Stroke (IMS) III Trial
Interventional Management of Stroke Trial: A Phase III Clinical Trial Examining Whether a Combined Intravenous (IV) and Intra-Arterial (IA) Approach to Recanalization is Superior to Standard IV Rt-PA (Activase®) Alone When Initiated Within Three Hours of Acute Ischemic Stroke Onset
Status: Archived
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Interventional Management of Stroke (IMS) III Trial
Interventional Management of Stroke Trial: A Phase III Clinical Trial Examining Whether a Combined Intravenous (IV) and Intra-Arterial (IA) Approach to Recanalization is Superior to Standard IV Rt-PA (Activase®) Alone When Initiated Within Three Hours of Acute Ischemic Stroke Onset
Status: Archived
Updated: 1/1/1970
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Interventional Management of Stroke (IMS) III Trial
Interventional Management of Stroke Trial: A Phase III Clinical Trial Examining Whether a Combined Intravenous (IV) and Intra-Arterial (IA) Approach to Recanalization is Superior to Standard IV Rt-PA (Activase®) Alone When Initiated Within Three Hours of Acute Ischemic Stroke Onset
Status: Archived
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Interventional Management of Stroke (IMS) III Trial
Interventional Management of Stroke Trial: A Phase III Clinical Trial Examining Whether a Combined Intravenous (IV) and Intra-Arterial (IA) Approach to Recanalization is Superior to Standard IV Rt-PA (Activase®) Alone When Initiated Within Three Hours of Acute Ischemic Stroke Onset
Status: Archived
Updated: 1/1/1970
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Interventional Management of Stroke (IMS) III Trial
Interventional Management of Stroke Trial: A Phase III Clinical Trial Examining Whether a Combined Intravenous (IV) and Intra-Arterial (IA) Approach to Recanalization is Superior to Standard IV Rt-PA (Activase®) Alone When Initiated Within Three Hours of Acute Ischemic Stroke Onset
Status: Archived
Allegheny Endocrinology Associates
mi
from
Pittsburgh, PA
Interventional Management of Stroke (IMS) III Trial
Interventional Management of Stroke Trial: A Phase III Clinical Trial Examining Whether a Combined Intravenous (IV) and Intra-Arterial (IA) Approach to Recanalization is Superior to Standard IV Rt-PA (Activase®) Alone When Initiated Within Three Hours of Acute Ischemic Stroke Onset
Status: Archived
Updated: 1/1/1970
Allegheny Endocrinology Associates
mi
from
Pittsburgh, PA
Interventional Management of Stroke (IMS) III Trial
Interventional Management of Stroke Trial: A Phase III Clinical Trial Examining Whether a Combined Intravenous (IV) and Intra-Arterial (IA) Approach to Recanalization is Superior to Standard IV Rt-PA (Activase®) Alone When Initiated Within Three Hours of Acute Ischemic Stroke Onset
Status: Archived
Medical University of South Carolina
mi
from
Charleston, SC
Interventional Management of Stroke (IMS) III Trial
Interventional Management of Stroke Trial: A Phase III Clinical Trial Examining Whether a Combined Intravenous (IV) and Intra-Arterial (IA) Approach to Recanalization is Superior to Standard IV Rt-PA (Activase®) Alone When Initiated Within Three Hours of Acute Ischemic Stroke Onset
Status: Archived
Updated: 1/1/1970
Medical University of South Carolina
mi
from
Charleston, SC
Interventional Management of Stroke (IMS) III Trial
Interventional Management of Stroke Trial: A Phase III Clinical Trial Examining Whether a Combined Intravenous (IV) and Intra-Arterial (IA) Approach to Recanalization is Superior to Standard IV Rt-PA (Activase®) Alone When Initiated Within Three Hours of Acute Ischemic Stroke Onset
Status: Archived
University Medical Center at Brackenridge Hospital
mi
from
Austin, TX
Interventional Management of Stroke (IMS) III Trial
Interventional Management of Stroke Trial: A Phase III Clinical Trial Examining Whether a Combined Intravenous (IV) and Intra-Arterial (IA) Approach to Recanalization is Superior to Standard IV Rt-PA (Activase®) Alone When Initiated Within Three Hours of Acute Ischemic Stroke Onset
Status: Archived
Updated: 1/1/1970
University Medical Center at Brackenridge Hospital
mi
from
Austin, TX
Interventional Management of Stroke (IMS) III Trial
Interventional Management of Stroke Trial: A Phase III Clinical Trial Examining Whether a Combined Intravenous (IV) and Intra-Arterial (IA) Approach to Recanalization is Superior to Standard IV Rt-PA (Activase®) Alone When Initiated Within Three Hours of Acute Ischemic Stroke Onset
Status: Archived
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Interventional Management of Stroke (IMS) III Trial
Interventional Management of Stroke Trial: A Phase III Clinical Trial Examining Whether a Combined Intravenous (IV) and Intra-Arterial (IA) Approach to Recanalization is Superior to Standard IV Rt-PA (Activase®) Alone When Initiated Within Three Hours of Acute Ischemic Stroke Onset
Status: Archived
Updated: 1/1/1970
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Interventional Management of Stroke (IMS) III Trial
Interventional Management of Stroke Trial: A Phase III Clinical Trial Examining Whether a Combined Intravenous (IV) and Intra-Arterial (IA) Approach to Recanalization is Superior to Standard IV Rt-PA (Activase®) Alone When Initiated Within Three Hours of Acute Ischemic Stroke Onset
Status: Archived
University of Virginia
mi
from
Charlottesville, VA
Interventional Management of Stroke (IMS) III Trial
Interventional Management of Stroke Trial: A Phase III Clinical Trial Examining Whether a Combined Intravenous (IV) and Intra-Arterial (IA) Approach to Recanalization is Superior to Standard IV Rt-PA (Activase®) Alone When Initiated Within Three Hours of Acute Ischemic Stroke Onset
Status: Archived
Updated: 1/1/1970
University of Virginia
mi
from
Charlottesville, VA
Interventional Management of Stroke (IMS) III Trial
Interventional Management of Stroke Trial: A Phase III Clinical Trial Examining Whether a Combined Intravenous (IV) and Intra-Arterial (IA) Approach to Recanalization is Superior to Standard IV Rt-PA (Activase®) Alone When Initiated Within Three Hours of Acute Ischemic Stroke Onset
Status: Archived
Medical College of Wisconsin
mi
from
Milwaukee, WI
Interventional Management of Stroke (IMS) III Trial
Interventional Management of Stroke Trial: A Phase III Clinical Trial Examining Whether a Combined Intravenous (IV) and Intra-Arterial (IA) Approach to Recanalization is Superior to Standard IV Rt-PA (Activase®) Alone When Initiated Within Three Hours of Acute Ischemic Stroke Onset
Status: Archived
Updated: 1/1/1970
Medical College of Wisconsin
mi
from
Milwaukee, WI
The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes
The Efficacy and Short-Term Safety of Docosahexaenoic Acid (DHA) and Statin Therapy for Subjects With Coronary Artery Disease or Cardiac Risk Equivalents With Moderate Hypertriglyceridemia (IIb)
Status: Archived
Maine Center for Lipids and Cardiovascular Health
mi
from
Scarborough, ME
The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes
The Efficacy and Short-Term Safety of Docosahexaenoic Acid (DHA) and Statin Therapy for Subjects With Coronary Artery Disease or Cardiac Risk Equivalents With Moderate Hypertriglyceridemia (IIb)
Status: Archived
Updated: 1/1/1970
Maine Center for Lipids and Cardiovascular Health
mi
from
Scarborough, ME
Study of the Arachidonate 5-Lipoxygenase Enzyme in Affecting the Risk for Coronary Heart Disease
Role of the Arachidonate 5-Lipoxygenase Pathway in Coronary Heart Disease
Status: Archived
University of Florida Family Practice Medical Group Clinic
mi
from
Gainesville, FL
Study of the Arachidonate 5-Lipoxygenase Enzyme in Affecting the Risk for Coronary Heart Disease
Role of the Arachidonate 5-Lipoxygenase Pathway in Coronary Heart Disease
Status: Archived
Updated: 1/1/1970
University of Florida Family Practice Medical Group Clinic
mi
from
Gainesville, FL
Effect of Low Socionomic Status and Psychosocial Factors on Cardiovascular Disease Risk in Mexican-American Women
Cardiovascular Risk Disparities: Socio-Emotional Pathways
Status: Archived
San Diego State University, Center for Behavioral and Community Health Research (BACH)
mi
from
San Diego, CA
Effect of Low Socionomic Status and Psychosocial Factors on Cardiovascular Disease Risk in Mexican-American Women
Cardiovascular Risk Disparities: Socio-Emotional Pathways
Status: Archived
Updated: 1/1/1970
San Diego State University, Center for Behavioral and Community Health Research (BACH)
mi
from
San Diego, CA
Abnormal 3-D MRI Flow Patterns in Adolescents Patients With Bicuspid Aortic Valve
Abnormal 3-dimensional MRI Flow Patterns and Plasma Matrix Metalloproteinase Levels Predict Dilatation of Ascending Aorta in Adolescent Patients With Bicuspid Aortic Valve
Status: Archived
Children`s Hospital of Philadelphia : University of Philadelphia
mi
from
Philadelphia, PA
Abnormal 3-D MRI Flow Patterns in Adolescents Patients With Bicuspid Aortic Valve
Abnormal 3-dimensional MRI Flow Patterns and Plasma Matrix Metalloproteinase Levels Predict Dilatation of Ascending Aorta in Adolescent Patients With Bicuspid Aortic Valve
Status: Archived
Updated: 1/1/1970
Children`s Hospital of Philadelphia : University of Philadelphia
mi
from
Philadelphia, PA
Mechanism of Percutaneous Revascularization for Coronary Bifurcation Disease
Insights Into the Mechanism of Percutaneous Revascularization of Coronary Bifurcation Disease in the Drug-Eluting Stent Era. An Angiographic and Intravascular Ultrasound Study. The INSIGHT Trial
Status: Archived
University of Florida Health Science Center - Jacksonville
mi
from
Jacksonville, FL
Mechanism of Percutaneous Revascularization for Coronary Bifurcation Disease
Insights Into the Mechanism of Percutaneous Revascularization of Coronary Bifurcation Disease in the Drug-Eluting Stent Era. An Angiographic and Intravascular Ultrasound Study. The INSIGHT Trial
Status: Archived
Updated: 1/1/1970
University of Florida Health Science Center - Jacksonville
mi
from
Jacksonville, FL
A Phase 2, Investigator-Initiated, Feasibility Study to Evaluate the Mechanisms of Coronary Endothelial Dysfunction Imaged As Resting Myocardial Perfusion Heterogeneity After Endothelin Receptor Blockade With Darusentan
A Phase 2, Investigator-Initiated, Feasibility Study to Evaluate the Mechanisms of Coronary Endothelial Dysfunction Imaged As Resting Myocardial Perfusion Heterogeneity After Endothelin Receptor Blockade With Darusentan
Status: Archived
Weatherhead PET Center for Preventing and Reversing Atherosclerosis, UT Medical School, Memorial Hermann Hospital
mi
from
Houston, TX
A Phase 2, Investigator-Initiated, Feasibility Study to Evaluate the Mechanisms of Coronary Endothelial Dysfunction Imaged As Resting Myocardial Perfusion Heterogeneity After Endothelin Receptor Blockade With Darusentan
A Phase 2, Investigator-Initiated, Feasibility Study to Evaluate the Mechanisms of Coronary Endothelial Dysfunction Imaged As Resting Myocardial Perfusion Heterogeneity After Endothelin Receptor Blockade With Darusentan
Status: Archived
Updated: 1/1/1970
Weatherhead PET Center for Preventing and Reversing Atherosclerosis, UT Medical School, Memorial Hermann Hospital
mi
from
Houston, TX
Phase II Combination Stem Cell Therapy for the Treatment of Severe Coronary Ischemia(CI)
Phase II Study for the Transfer of Bone Marrow-Derived Mononuclear and Mesenchymal StemCells Into the Myocardium for the Treatment of Severe Coronary Ischemia
Status: Archived
TCA Cellular Therapy
mi
from
Covington, LA
Phase II Combination Stem Cell Therapy for the Treatment of Severe Coronary Ischemia(CI)
Phase II Study for the Transfer of Bone Marrow-Derived Mononuclear and Mesenchymal StemCells Into the Myocardium for the Treatment of Severe Coronary Ischemia
Status: Archived
Updated: 1/1/1970
TCA Cellular Therapy
mi
from
Covington, LA
Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial
Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial
Status: Archived
Tufts Clinical Pharmacology Study Unit
mi
from
Boston, MA
Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial
Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial
Status: Archived
Updated: 1/1/1970
Tufts Clinical Pharmacology Study Unit
mi
from
Boston, MA
Drug Eluting Stent Registry of Thrombosis
Drug Eluting Stent Registry of Thrombosis
Status: Archived
Mercy General Hospital
mi
from
Sacramento, CA
Drug Eluting Stent Registry of Thrombosis
Drug Eluting Stent Registry of Thrombosis
Status: Archived
Updated: 1/1/1970
Mercy General Hospital
mi
from
Sacramento, CA
Drug Eluting Stent Registry of Thrombosis
Drug Eluting Stent Registry of Thrombosis
Status: Archived
Washington Hospital Center
mi
from
Washington,
Drug Eluting Stent Registry of Thrombosis
Drug Eluting Stent Registry of Thrombosis
Status: Archived
Updated: 1/1/1970
Washington Hospital Center
mi
from
Washington,
Drug Eluting Stent Registry of Thrombosis
Drug Eluting Stent Registry of Thrombosis
Status: Archived
Lexington Cardiac Research Foundation/Central Baptist Hospital
mi
from
Lexington, KY
Drug Eluting Stent Registry of Thrombosis
Drug Eluting Stent Registry of Thrombosis
Status: Archived
Updated: 1/1/1970
Lexington Cardiac Research Foundation/Central Baptist Hospital
mi
from
Lexington, KY
Drug Eluting Stent Registry of Thrombosis
Drug Eluting Stent Registry of Thrombosis
Status: Archived
Washington Adventist Hospital
mi
from
Takoma Park, MD
Drug Eluting Stent Registry of Thrombosis
Drug Eluting Stent Registry of Thrombosis
Status: Archived
Updated: 1/1/1970
Washington Adventist Hospital
mi
from
Takoma Park, MD
Drug Eluting Stent Registry of Thrombosis
Drug Eluting Stent Registry of Thrombosis
Status: Archived
St Luke'S Hospital And Health Network
mi
from
Bethlehem, PA
Drug Eluting Stent Registry of Thrombosis
Drug Eluting Stent Registry of Thrombosis
Status: Archived
Updated: 1/1/1970
St Luke'S Hospital And Health Network
mi
from
Bethlehem, PA
Drug Eluting Stent Registry of Thrombosis
Drug Eluting Stent Registry of Thrombosis
Status: Archived
The Valley Hospital
mi
from
Ridgewood, NJ
Drug Eluting Stent Registry of Thrombosis
Drug Eluting Stent Registry of Thrombosis
Status: Archived
Updated: 1/1/1970
The Valley Hospital
mi
from
Ridgewood, NJ
Drug Eluting Stent Registry of Thrombosis
Drug Eluting Stent Registry of Thrombosis
Status: Archived
New York Methodist Hospital
mi
from
Brooklyn, NY
Drug Eluting Stent Registry of Thrombosis
Drug Eluting Stent Registry of Thrombosis
Status: Archived
Updated: 1/1/1970
New York Methodist Hospital
mi
from
Brooklyn, NY
Drug Eluting Stent Registry of Thrombosis
Drug Eluting Stent Registry of Thrombosis
Status: Archived
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Drug Eluting Stent Registry of Thrombosis
Drug Eluting Stent Registry of Thrombosis
Status: Archived
Updated: 1/1/1970
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Drug Eluting Stent Registry of Thrombosis
Drug Eluting Stent Registry of Thrombosis
Status: Archived
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Drug Eluting Stent Registry of Thrombosis
Drug Eluting Stent Registry of Thrombosis
Status: Archived
Updated: 1/1/1970
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Drug Eluting Stent Registry of Thrombosis
Drug Eluting Stent Registry of Thrombosis
Status: Archived
Summa Health System
mi
from
Akron, OH
Drug Eluting Stent Registry of Thrombosis
Drug Eluting Stent Registry of Thrombosis
Status: Archived
Updated: 1/1/1970
Summa Health System
mi
from
Akron, OH
Drug Eluting Stent Registry of Thrombosis
Drug Eluting Stent Registry of Thrombosis
Status: Archived
The Miriam Hospital Weight Control and Diabetes Research Center
mi
from
Providence, RI
Drug Eluting Stent Registry of Thrombosis
Drug Eluting Stent Registry of Thrombosis
Status: Archived
Updated: 1/1/1970
The Miriam Hospital Weight Control and Diabetes Research Center
mi
from
Providence, RI
Drug Eluting Stent Registry of Thrombosis
Drug Eluting Stent Registry of Thrombosis
Status: Archived
South Carolina Heart Center
mi
from
Columbia, SC
Drug Eluting Stent Registry of Thrombosis
Drug Eluting Stent Registry of Thrombosis
Status: Archived
Updated: 1/1/1970
South Carolina Heart Center
mi
from
Columbia, SC
Local Paclitaxel Delivery for SFA Disease
Treatment of Superficial Femoral Artery Atherosclerotic Disease With Local Delivery of Paclitaxel Using an Irrigating Catheter: a Randomized, Single-center Pilot Study
Status: Archived
University of Oklahoma College of Medicine
mi
from
Oklahoma City, OK
Local Paclitaxel Delivery for SFA Disease
Treatment of Superficial Femoral Artery Atherosclerotic Disease With Local Delivery of Paclitaxel Using an Irrigating Catheter: a Randomized, Single-center Pilot Study
Status: Archived
Updated: 1/1/1970
University of Oklahoma College of Medicine
mi
from
Oklahoma City, OK
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Internal Medicine Physicians Associates
mi
from
Phoenix, AZ
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Updated: 1/1/1970
Internal Medicine Physicians Associates
mi
from
Phoenix, AZ
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Tatum Ridge Internal Medicine
mi
from
Phoenix, AZ
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Updated: 1/1/1970
Tatum Ridge Internal Medicine
mi
from
Phoenix, AZ
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Central Arkansas Veterans Healthcare System
mi
from
Little Rock, AR
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Updated: 1/1/1970
Central Arkansas Veterans Healthcare System
mi
from
Little Rock, AR
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Veterans Affairs Medical Center - New York
mi
from
New York, NY
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Updated: 1/1/1970
Veterans Affairs Medical Center - New York
mi
from
New York, NY
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
University of California, Davis Medical Center
mi
from
Sacramento, CA
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Updated: 1/1/1970
University of California, Davis Medical Center
mi
from
Sacramento, CA
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Apex Research Institute
mi
from
Santa Ana, CA
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Updated: 1/1/1970
Apex Research Institute
mi
from
Santa Ana, CA
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Aurora Denver Cardiology Associates
mi
from
Aurora, CO
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Updated: 1/1/1970
Aurora Denver Cardiology Associates
mi
from
Aurora, CO
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Pensacola Research Consultants, Inc.
mi
from
Pensacola, FL
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Updated: 1/1/1970
Pensacola Research Consultants, Inc.
mi
from
Pensacola, FL
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
DMI Healthcare Group, Inc.
mi
from
Pinellas Park, FL
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Updated: 1/1/1970
DMI Healthcare Group, Inc.
mi
from
Pinellas Park, FL
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Ochsner Medical Center
mi
from
New Orleans, LA
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Updated: 1/1/1970
Ochsner Medical Center
mi
from
New Orleans, LA
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
HPV Heart, PA
mi
from
Columbia, MD
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Updated: 1/1/1970
HPV Heart, PA
mi
from
Columbia, MD
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Umass Memorial Medical Center
mi
from
Worcester, MA
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Updated: 1/1/1970
Umass Memorial Medical Center
mi
from
Worcester, MA
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Darien Pediatric Associates
mi
from
Darien, CT
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Updated: 1/1/1970
Darien Pediatric Associates
mi
from
Darien, CT
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Strong Memorial Hospital (University of Rochester School of Medicine)
mi
from
Rochester, NY
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Updated: 1/1/1970
Strong Memorial Hospital (University of Rochester School of Medicine)
mi
from
Rochester, NY
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Durham VA Medical Center
mi
from
Durham, NC
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Updated: 1/1/1970
Durham VA Medical Center
mi
from
Durham, NC
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Radiant Research Inc.
mi
from
Chicago, IL
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Updated: 1/1/1970
Radiant Research Inc.
mi
from
Chicago, IL
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Jobst Vascular Center
mi
from
Toledo, OH
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Updated: 1/1/1970
Jobst Vascular Center
mi
from
Toledo, OH
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Peripheral Vascular Associates
mi
from
San Antonio, TX
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Updated: 1/1/1970
Peripheral Vascular Associates
mi
from
San Antonio, TX
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Updated: 1/1/1970
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Radiant Research
mi
from
Las Vegas, NV
Evaluation of Cilostazol in Combination With L-Carnitine
Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication
Status: Archived
Updated: 1/1/1970
Radiant Research
mi
from
Las Vegas, NV